Skip to main content
Premium Trial:

Request an Annual Quote

Cytena x.sight Single-Cell Printers

Cytena has launched three new single-cell printers, called c.sight, f.sight, and b.sight, that are part of its x.sight line of instruments. The c.sight instrument is designed for cell line development and single-cell genomics and can be operated outside a sterile bench. The f.sight device has two cameras, which can be controlled independently, to capture bright field and fluorescence signals simultaneously. In addition, it has an adjustable laser. The b.sight system enables the isolation of cells in the sub-micron range and printing single-cell bacteria. It has high-resolution optics and requires no staining or labeling of the cells. Cytena has also updated the software for all its single-cell printers, allowing them to be integrated into robotic platforms.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.